Sponsor Check › Person
Named as an officer, director or promoter on SEC Form D filings · ME, MA, CO · Sep 15, 2009 → Jul 11, 2017
Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:19 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET
Peter Barton Hutt is listed as a director on 60 SEC Form D filings by 15 issuers between Jun 2009 and Apr 2025. Largest by amount reported sold: Moderna Therapeutics, Inc. (Cambridge, MA — biotechnology — 2016; $451.4M reported sold to 72 investors), Moderna LLC (Cambridge, MA — pharmaceuticals — 2013–2015; $446.1M reported sold to 43 investors), Cartesian Therapeutics, Inc. (Gaithersburg, MD — biotechnology — 2010–2017; $130M reported sold to 26 investors), Rubius Therapeutics, Inc. (Cambridge, MA — biotechnology — 2017; $115M reported sold to 27 investors), Seres Health, Inc. (Cambridge, MA — pharmaceuticals — 2014–2015; $65M reported sold to 20 investors) and 10 more (all listed below).
What this means That is a lot of deals — 15 separate companies raised money with this person listed as director, over about 16 years. Across those companies the filings report $1.4B sold in total.
Listed alongside Robert Langer (42 shared filings), Alan Crane (18 shared filings), Noubar Afeyan (18 shared filings), Omid Farokhzad (18 shared filings), Amir Nashat (16 shared filings) and 116 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Peter. Each name links to their own page.
The issuers belong to 2 sponsor groups: Moderna (2 issuers, $897.4M reported sold, 2013–2016) and Proterris (2 issuers, $5.46M reported sold, 2019–2022).
What this means This person is listed across more than one sponsor team; each group page shows that team's full track record.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared the newest 50 of 60 public filings for Peter Barton Hutt and found 13 differences, 1 worth asking the sponsor about: 10 Form Ds were filed more than 15 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.
Community search for Peter Barton Hutt has not run yet — it is #8,342 of 32,124 in line; searches run around the clock at the hosts' allowed rate. Searched so far: 638 names.
Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.
Five things investors ask first. Items still in human review are counted, not shown.
None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026
Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:19 AM ET.
State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: 48 regulators (FINRA, NASAA, 37 states) — crawled Oct 24, 2026, 8:48 AM ET
SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Peter Barton Hutt..
State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).
None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026
Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:19 AM ET.
State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
Comparisons cover issuers and sponsor groups — see the issuer pages under Deals
13 differences found between the filings for Peter Barton Hutt — 1 worth asking about (compared the newest 50 of 60 filings on Oct 24, 2026; older filings not covered)
United States Bankruptcy Court, D. Massachusetts docket "David Siewers" filed Jan 26, 1990, closed Aug 18, 1992. David Siewers (listed on the same filings) is listed as Debtor ("David Siewers"). Our match estimate: 65%.
What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.
The Aug 30, 2021 Form D reports $525,000 sold and $93,333 of the proceeds used for payments to officers, directors or promoters.
What this means The filing reports how much of the money raised was paid to insiders. Over 10% is high for most deals. Ask what it paid for.
Proterris Inc. (last filing Aug 23, 2019; $1,999,999 sold of $25,000,000). Each has no filing in more than two years and reported under half its target sold.
What this means An issuer whose last filing is more than two years old and reported under half its target sold. The raise may have closed early or quietly stopped. Ask what happened to each.
Form D filed 140 days after the first sale — CEREHEALTH CORP · Form D filed 19 days after the first sale — Florey Biosciences, Inc. · Form D filed 17 days after the first sale — CEREHEALTH CORP · Form D filed 23 days after the first sale — Proterris Inc. · Form D filed 27 days after the first sale — SEVENTH SENSE BIOSYSTEMS, INC. · and 5 more
What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.
No amendment in the last 12 months on an offering that may still be open — Florey Biosciences, Inc. (latest filing Apr 29, 2025) · No amendment in the last 12 months on an offering that may still be open — CEREHEALTH CORP (latest filing Aug 10, 2023) · No amendment in the last 12 months on an offering that may still be open — Proterris Inc. (latest filing Aug 23, 2019) · No amendment in the last 12 months on an offering that may still be open — SEVENTH SENSE BIOSYSTEMS, INC. (latest filing Aug 22, 2018) · No amendment in the last 12 months on an offering that may still be open — SEVENTH SENSE BIOSYSTEMS, INC. (latest filing Feb 21, 2018) · and 18 more
What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.
Offering amount changed between filings — Axcella Health Inc. · Offering amount changed between filings — Axcella Health Inc. · Offering amount lowered between filings — SEVENTH SENSE BIOSYSTEMS, INC. · Offering amount changed between filings — Axcella Health Inc. · Offering amount changed between filings — Moderna LLC · and 1 more
What this means Targets change as deals grow or shrink. Ask whether later money has the same terms.
listed as "Peter Hutt" on 22 filings (from May 10, 2011), and "Peter Barton Hutt" on 29 filings (from Nov 17, 2011).
What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.
This page covers filings where the address state is ME or MA or CO. A separate record, "Peter Barton Hutt" with address state CA, is listed on 5 filings — most recently by CoLabs Int'l, Corp. (Jun 2, 2023). Both records have filings in the same period (Aug 6, 2015 to Jul 11, 2017).
What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.
This page covers filings where the address state is ME or MA or CO. A separate record, "Peter Barton Hutt" with address state VA, is listed on 1 filing — most recently by Atelerix Life Sciences Inc. (Oct 3, 2022). The two records do not overlap in time: this page runs Sep 15, 2009 to Jul 11, 2017; the other has one filing dated Oct 3, 2022.
What this means Could be the same person who moved, or two people with the same name. We keep them apart until a filing ties them together. Check both pages before you decide.
This page covers filings where the address state is ME or MA or CO. A separate record, "Peter Hutt" with address state TX, is listed on 2 filings — most recently by NanoMedical Systems Inc (Aug 9, 2013). Both records have filings in the same period (Dec 19, 2012 to Aug 9, 2013).
What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.
This page covers filings where the address state is ME or MA or CO. A separate record, "Peter Barton Hutt" with address state UT, is listed on 1 filing — most recently by Q Holdings, Inc. (Jul 27, 2012). Both records have filings in the same period (Jul 27, 2012).
What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.
The people listed on the Nov 16, 2016 filing give Cambridge, MA; on the Sep 20, 2017 filing they give Medford, MA. The address now on file (200 Boston Avenue, Suite 3700, Medford, MA) is a registered-agent or shared-office address used by 8 issuers.
What this means A registered agent's address is a mailbox, not where the team works. Ask where the business actually operates.
MA on 47 filings (May 10, 2011 to Apr 29, 2025); CO on 4 filings (Apr 29, 2020 to Aug 10, 2023).
What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.
What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. We compared the newest 50 of 60 filings (work cap); older filings are not covered here. As of Oct 24, 2026.
3 of 50 offerings report sales commissions totalling $2,749,375; 2 report finder's fees totalling $1,137,864; 1 reports proceeds to related persons totalling $102,083. (includes amounts the issuer reported as estimates)
| Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it | Source |
|---|---|---|---|---|---|
| Apr 29, 2025 D Florey Biosciences, Inc. File 021-544696 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Aug 10, 2023 D/A CEREHEALTH CORP File 021-411732 | $0 | $0 | $102,083 | None listed on this filing | EDGAR ↗ |
| Apr 29, 2020 D CEREHEALTH CORP File 021-365960 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Aug 23, 2019 D Proterris Inc. File 021-347268 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Aug 22, 2018 D SEVENTH SENSE BIOSYSTEMS, INC. File 021-319773 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Feb 21, 2018 D SEVENTH SENSE BIOSYSTEMS, INC. File 021-306068 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Sep 20, 2017 D SEVENTH SENSE BIOSYSTEMS, INC. File 021-295080 | $17,500 | $0 | $0 | OUISA CAPITAL LLC BrokerCheck CRD 102840 ↗ | EDGAR ↗ |
| Jul 11, 2017 D Cartesian Therapeutics, Inc. File 021-290444 | $2,640,000 (est.) | $0 | $0 | Stifel, Nicolaus & Company Incorporated BrokerCheck CRD 793 ↗ | EDGAR ↗ |
| Jun 22, 2017 D Rubius Therapeutics, Inc. File 021-289273 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Feb 24, 2017 D/A Axcella Health Inc. File 021-258026 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Dec 14, 2016 D Cartesian Therapeutics, Inc. File 021-276281 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Nov 16, 2016 D SEVENTH SENSE BIOSYSTEMS, INC. File 021-274591 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Aug 24, 2016 D Moderna Therapeutics, Inc. File 021-269500 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Feb 24, 2016 D/A Axcella Health Inc. File 021-234192 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Dec 22, 2015 D SEVENTH SENSE BIOSYSTEMS, INC. File 021-253617 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Sep 10, 2015 D Cartesian Therapeutics, Inc. File 021-247362 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Aug 6, 2015 D/A SEVENTH SENSE BIOSYSTEMS, INC. File 021-222564 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Apr 23, 2015 D Cartesian Therapeutics, Inc. File 021-238498 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jan 5, 2015 D Seres Health, Inc. File 021-231428 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jan 5, 2015 D Moderna LLC File 021-231445 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Dec 2, 2014 D Seres Health, Inc. File 021-229277 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Aug 28, 2014 D Cartesian Therapeutics, Inc. File 021-223752 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Aug 6, 2014 D Salarius Pharmaceuticals, Inc. File 021-222417 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jul 15, 2014 D Cartesian Therapeutics, Inc. File 021-221143 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jun 18, 2014 D SEVENTH SENSE BIOSYSTEMS, INC. File 021-219417 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jun 9, 2014 D Seres Health, Inc. File 021-218762 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Apr 10, 2014 D SEVENTH SENSE BIOSYSTEMS, INC. File 021-215310 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Apr 9, 2014 D Cartesian Therapeutics, Inc. File 021-215195 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Mar 12, 2014 D Tarveda Therapeutics, Inc. File 021-213366 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jan 23, 2014 D/A Moderna LLC File 021-206659 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Dec 24, 2013 D/A Tarveda Therapeutics, Inc. File 021-188774 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Nov 21, 2013 D SEVENTH SENSE BIOSYSTEMS, INC. File 021-206725 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Apr 1, 2013 D SEVENTH SENSE BIOSYSTEMS, INC. File 021-194292 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Mar 18, 2013 D SEVENTH SENSE BIOSYSTEMS, INC. File 021-193494 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Feb 25, 2013 D LIVING PROOF INC File 021-192312 | $0 | $1,122,864 | $0 | Leerink Swann LLC BrokerCheck CRD 39011 ↗ via Daniel Dubin (CRD 3231063 ↗) | EDGAR ↗ |
| Feb 8, 2013 D BIND Biosciences, Inc File 021-191591 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jun 19, 2012 D/A SEVENTH SENSE BIOSYSTEMS, INC. File 021-159505 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jun 1, 2012 D SEVENTH SENSE BIOSYSTEMS, INC. File 021-179118 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Apr 10, 2012 D SEVENTH SENSE BIOSYSTEMS, INC. File 021-176410 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Nov 22, 2011 D BIND Biosciences, Inc File 021-169119 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Nov 17, 2011 D Cartesian Therapeutics, Inc. File 021-168905 | $0 | $0 | $0 None other than salaries and bonuses in the ordinary course of business. | None listed on this filing | EDGAR ↗ |
| Nov 17, 2011 D Cartesian Therapeutics, Inc. File 021-168906 | $0 | $0 | $0 None other than salaries and bonuses in the ordinary course of business. | None listed on this filing | EDGAR ↗ |
| Oct 13, 2011 D BIND Biosciences, Inc File 021-167172 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Sep 2, 2011 D Tarveda Therapeutics, Inc. File 021-165360 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Oct 14, 2010 D SEVENTH SENSE BIOSYSTEMS, INC. File 021-149086 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jun 29, 2010 D BIND Biosciences, Inc File 021-144139 | $0 | $0 | $0 Not including salaries and bonuses paid to executive officers in the ordinary course of business. | None listed on this filing | EDGAR ↗ |
| Jun 4, 2010 D SEVENTH SENSE BIOSYSTEMS, INC. File 021-142974 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Apr 6, 2010 D Cartesian Therapeutics, Inc. File 021-125893 | $0 | $0 | $0 None other than salaries and bonuses in the ordinary course of business. | None listed on this filing | EDGAR ↗ |
| Sep 15, 2009 D Pervasis Therapeutics Inc File 021-71452 | $91,875 (est.) | $15,000 | $0 | Musket Research Associates, Inc. BrokerCheck CRD 30599 ↗ via David B. Musket (CRD 1321808 ↗) | EDGAR ↗ |
| Jun 18, 2009 D LIVING PROOF INC File 021-108750 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.
Counted across every filing this person is listed on (latest filing per offering, per issuer).
Every issuer that named Peter Barton Hutt on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.
Raised $1.4M from 1 investor (32% of the $4.4M target) as of the latest filing. Peter is listed as director.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $5.19M from 47 investors (99% of the $5.25M target) as of the latest filing. Peter is listed as director on 4 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $2M from 1 investor (8% of the $25M target) as of the latest filing. Peter is listed as director.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $18.5M from 18 investors (90% of the $20.5M target) as of the latest filing. Peter is listed as director on 18 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $130M from 26 investors (100% of the $50M target) as of the latest filing. Peter is listed as director on 10 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $115M from 27 investors (96% of the $120M target) as of the latest filing. Peter is listed as director.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $44.3M from 12 investors as of the latest filing. Peter is listed as director on 6 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $451.4M from 72 investors (75% of the $600M target) as of the latest filing. Peter is listed as director.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $446.1M from 43 investors (89% of the $502.2M target) as of the latest filing. Peter is listed as director on 3 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $65M from 20 investors (100% of the $65M target) as of the latest filing. Peter is listed as director on 3 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $16.2M from 20 investors (74% of the $22M target) as of the latest filing. Peter is listed as director.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $38M from 13 investors (100% of the $1000K target) as of the latest filing. Peter is listed as director on 4 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $30M from 9 investors (86% of the $35M target) as of the latest filing. Peter is listed as director on 2 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.
Raised $25.5M from 21 investors (100% of the $20.3M target) as of the latest filing. Peter is listed as director on 4 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.
Raised $10M from 18 investors (58% of the $17.4M target) as of the latest filing. Peter is listed as director.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.
Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.
Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.
Robert Langer is on 48 issuers in total — a repeat sponsor. Their page lists every one.
Noubar Afeyan is on 14 issuers in total — a repeat sponsor. Their page lists every one.
Alan Crane is on 12 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.
Amir Nashat is on 29 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.
Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.
Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.
HARRY WILCOX is on 7 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.
Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.
Edwin M. Kania, Jr. is on 6 issuers in total — a repeat sponsor. Their page lists every one.
Robert Connelly is on 5 issuers in total — a repeat sponsor. Their page lists every one.
David Berry is on 14 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.
Carl L. Gordon is on 62 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.
Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.
Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.
Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.
Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.
Charles Cooney is on 8 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.
Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.
Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.
Lorence Kim is on 7 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.
James Barrett is on 7 issuers in total — a repeat sponsor. Their page lists every one.
Stephane Bancel is on 5 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.
Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.
Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.
Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.
Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.
Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.
Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.
Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.
Listed on the same filings as Peter Barton Hutt. Their page shows their other deals.
One team, 2 deal companies. Peter Barton Hutt is listed on 2 of them.
Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Peter Barton Hutt.
One team, 2 deal companies. Peter Barton Hutt is listed on 1 of them.
Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Peter Barton Hutt.
A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.
Individuals are not matched to business registrations — registries list companies, and a name alone is not enough to tie a person to one. Officers and managers appear by name inside each matched company's record on the issuer pages. Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file).
None of the 15 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.
Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.
Property records are matched to companies only, never to individuals, so none are matched to Peter Barton Hutt by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 15 issuers this person is listed on — nothing matched.
Websites and social links of the issuers Peter Barton Hutt is listed on: none on file. No website or social profile named in Moderna Therapeutics, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #282,923 of 374,652 in line (1,386 issuers searched so far). One-tap searches: Look further ↓
One-tap searches on sites we do not index ourselves, with the name pre-filled (Cambridge, MA). Each opens in a new tab; what you find there is not verified by PartnerFacts.
No corrections have been requested for this page.
Free. Logged with status: received → under review → fixed / confirmed with source.
If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.
Members get an email when Peter Barton Hutt appears on a new Form D, or when a court case or SEC action is matched to them. See plans →